Post-marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ryzodeg®
Status:
Completed
Trial end date:
2018-11-24
Target enrollment:
Participant gender:
Summary
This trial is conducted in Asia. The aim of this Non-interventional study is to investigate
the long-term safety and effectiveness of Ryzodeg® (insulin degludec/insulin aspart) in
Japanese patients with diabetes mellitus requiring insulin therapy under normal clinical
practice conditions.